Markets · 1 sources covering this

Novo Nordisk Slides as Forecast Boost Fails to Impress

Novo Nordisk A/S raised its forecasts for the second time this year, citing higher expectations for its obesity and diabetes drug sales, though the magnitude of the increase failed to impress investors.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

BloombergLean L·1h ago
Novo Nordisk Slides as Forecast Boost Fails to Impress
Novo Nordisk A/S raised its forecasts for the second time this year, citing higher expectations for its obesity and diabetes drug sales, though the magnitude of the increase failed to impress investors.
Read at Bloomberg →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/e1cb3920e83b3afd58f5bb288bc04c6b29ba213f"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Novo Nordisk Slides as Forecast Boost Fails to Impress"></iframe>

Novo Nordisk Slides as Forecast Boost Fails to Impress

How 1 sources are covering this

Novo Nordisk Slides as Forecast Boost Fails to Impress

More from Markets

Bloomberg News Now

Jefferies Gets New Evidence of Fake Invoices at Beleaguered Fund

OPEC Output Rose in July Led by Gulf Nations, Survey Shows

Europe's Key Rivers are Drying Up As Extreme Heat Impact Widens

Reader

Trust & legal

Across the network